Merck Animal Health, NEADS launch educational service dog campaignMay 22, 2019A new educational campaign highlights the importance of keeping service dogs healthy from fleas and ticks. Through Bravecto Cares, Merck Animal Health will donate a portion of every Bravecto sale to National Education for Assistance Dog Services (NEADS) World Class Service Dogs from now until June 30. The funds raised will be used to support the training of NEADS Service Dogs. "Merck Animal Health knows how important it is to protect our pets, especially those that work for us," says Mark Pelham, DVM, companion animal professional services, Merck Animal Health. "More than just a nuisance, fleas and ticks can carry illness, such as Lyme disease, to our pets and our families. We are proud to collaborate with NEADS, an organization that shares our dedication to keeping pets healthy as part of their extensive service dog training program." According to NEADS, being in top health is a major factor for a world-class service dog. "The health of our dogs is as important as their task training—if they are not at optimal health, they will not be at ideal performance and can potentially put their handlers at risk," says Cathy Zemaitis, NEADS director of development. As part of the campaign, Merck is …
SPONSORED CONTENTOne dose protects for 12 months.One ProHeart® 12 (moxidectin) injection puts compliance in your control. + Get started
Elanco announces FDA approval of new flea, tick preventiveJanuary 24, 2018Elanco Animal Health, a division of Eli Lilly and Co., announced that Credelio has been approved by the FDA. Credelio is a new monthly oral tick and flea option for dogs that contains the patented active ingredient lotilaner, which targets the nervous system receptors of ticks and fleas, not dogs, according to the company. The preventive protects against lone star, American dog, black-legged, and brown dog ticks, as well as fleas. "When choosing pet medications, veterinarians and pet owners are most concerned with safety for the pet as well as efficacy of the product. Lotilaner, the active ingredient in Credelio, was selected from hundreds of candidate molecules with this in mind," said Tony Rumschlag, DVM, director, regional consulting for Elanco. "This new tasty chewable is fast-acting and effective against ticks and fleas, while being easy on dogs and puppies." In a field study, 100 percent of Credelio tablets were administered successfully and dogs accepted 94 percent of them when offered by hand, in an empty bowl, or with food, according to the company. The product's active ingredient—lotilaner—circulates in the dog's blood stream, targeting the receptors of ticks and fleas when they bite the dog. In clinical studies, it killed 100 …